Back to Trades
Davidson Matt
President and CEODirectorCIK 0001741937
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Davidson Matt, President and CEO, Director, has filed 4 SEC reports (2026), all concentrated in Azora Therapeutics, Inc. (DE) (AZR), totaling $1.1M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Nov 4 | AZR Azora Therapeutics, Inc. (DE) | Davidson Matt | President and CEO, Director | Conversion | $0 |
| Oct 30 | ADIL ADIAL PHARMACEUTICALS, INC. | Davidson Matt | President and CEO, Director | Grant | $414.9K |
| Jun 16 | ADIL ADIAL PHARMACEUTICALS, INC. | Davidson Matt | Chief Development Officer, Director | Grant | $671.7K |
| Jun 16 | ADIL ADIAL PHARMACEUTICALS, INC. | Davidson Matt | Chief Development Officer, Director | Other | $0 |
4 filings